A couple weeks ago, we told you about how a new coronavirus vaccine is expected to roll out in a matter of days, and how it’s still unclear whether the vaccine will be ready for people by June.
Well, it looks like that’s still not happening.
We’re now hearing that the CDC has revised the timeline for when people can get their vaccine.
According to a report from Axios, a CDC official said Thursday that they expect to start distributing the CNV-19 vaccine by June 1.
That’s about a month after the first dose is expected for the general population, and a month before the last dose is due for people 65 and older.
It’s unclear if that will still happen after the CVAV1 is also out for all Americans.
What makes this news even more worrisome is that the vaccine has yet to be licensed to any drugstore or pharmacy in the U.S. There are currently no other CVAVs on the market, and the vaccine only gets approved for use once it’s certified by the FDA to be safe and effective.
As of now, the only people who can get the vaccine are people over 65 who have health insurance or have had it for at least six months.
The vaccine is designed to protect against the virus and is administered in a special, nasal spray capsule that is placed under the tongue and injected into the mouth.
The vaccine also has to be taken every day and a daily dose is required to maintain the immune system and protect against viral replication.
But the CDC also warns that it will take longer for the vaccine to be fully effective if there is an increased risk of side effects, such as cough or sore throat.
It’s also important to note that the CVR1 vaccine is only one of a new class of vaccines currently in development, and that these vaccines are only available to those who have insurance.
The other vaccines being developed by the company are likely to be the same.
In the meantime, if you have a question about getting the CVS vaccine or the vaccine coverage update, you can call the CDC toll-free helpline at 1-800-CDC-INFO (1-800.232.5332) or visit the CDC website.